Source: centralcharts

Press Release: Rexahn : INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Rexahn Pharmaceuticals, Inc.- REXN

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Rexahn Pharmaceuticals, Inc.- REXN PR Newswire NEW YORK, July 7, 2020 NEW YORK , July...

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Douglas J. Swirsky's photo - President & CEO of Rexahn

President & CEO

Douglas J. Swirsky

CEO Approval Rating

86/100

Read more